Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma
Nivolumab response rate is 40% in metastatic melanoma. Few studies have evaluated pre-treatment biomarkers predictive of response. The aim of this study was to identify potential peripheral blood biomarkers associated with survival in patients with advanced melanoma treated with nivolumab. All advan...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medical Journals Sweden
2018-01-01
|
| coleção: | Acta Dermato-Venereologica |
| Assuntos: | |
| Acesso em linha: |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2872
|
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|